MedPath

Nordic Bioscience A/S

Nordic Bioscience A/S logo
🇩🇰Denmark
Ownership
Holding
Established
1991-01-01
Employees
51
Market Cap
-
Website
http://www.nordicbioscience.com

Clinical Trials

8

Active:0
Completed:7

Trial Phases

3 Phases

Phase 1:2
Phase 3:3
Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (37.5%)
Phase 3
3 (37.5%)
Phase 1
2 (25.0%)

Dose Finding Evaluation of Kudzu Root Extract in Women With Menopause Symptoms

Not Applicable
Completed
Conditions
Menopause
First Posted Date
2020-09-17
Last Posted Date
2020-09-18
Lead Sponsor
Nordic Bioscience A/S
Target Recruit Count
50
Registration Number
NCT04552106
Locations
🇩🇰

Sanos Clinic, Herlev, Denmark

The Effect of Exercise on Serum Levels of Collagen and Proteoglycan in Patients With Knee Osteoarthritis

Not Applicable
Completed
Conditions
Osteoarthritis, Knee
First Posted Date
2020-09-09
Last Posted Date
2021-06-08
Lead Sponsor
Nordic Bioscience A/S
Target Recruit Count
40
Registration Number
NCT04542668
Locations
🇩🇰

Rigshospitalet, Copenhagen, Denmark

The Effect of Exercise on Serum Levels of Collagen and Proteoglycan in Patients With Knee Osteoarthritis (EFEX-OA-01)

Not Applicable
Completed
Conditions
Osteoarthritis, Knee
First Posted Date
2020-09-09
Last Posted Date
2021-02-15
Lead Sponsor
Nordic Bioscience A/S
Target Recruit Count
40
Registration Number
NCT04542655
Locations
🇩🇰

Sanos Clinic, Herlev, Denmark

Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)

Phase 3
Terminated
Conditions
Osteoarthritis
Interventions
First Posted Date
2008-06-25
Last Posted Date
2019-04-24
Lead Sponsor
Nordic Bioscience A/S
Target Recruit Count
1030
Registration Number
NCT00704847
Locations
🇺🇸

Achieve Clinical Research, LLC, Tuscaloosa, Alabama, United States

🇺🇸

Center for Healthy Aging, Sacramento, California, United States

🇺🇸

Northwestern Center for Clinical Research, Chicago, Illinois, United States

and more 15 locations

A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D

Phase 3
Completed
Conditions
Osteoporosis
Interventions
Drug: SMC021 Placebo
First Posted Date
2007-09-06
Last Posted Date
2012-10-29
Lead Sponsor
Nordic Bioscience A/S
Target Recruit Count
4665
Registration Number
NCT00525798
Locations
🇺🇸

United Osteporosis Centers, Gainesville, Georgia, United States

🇺🇸

Michigan Bone & Mineral Clinic PC,, Detroit, Michigan, United States

🇺🇸

Oregon Osteoporosis Center, Portland, Oregon, United States

and more 13 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.